Publications searcher The science produced by our scientists is very important. In 2022, 1,629 papers were published in scientific journals with a global impact factor of over 15,000 points. Fulltext search Alphabetic A-Z Alphabetic Z-A Persistent reduction of retinal microvascular vessel density in patients with moderate and severe COVID-19 disease. PMID: 35039796 Journal: BMJ open ophthalmology Year: 2022 Reference: BMJ Open Ophthalmol. 2022 Jan 11;7(1):e000867. doi: 10.1136/bmjophth-2021-000867. eCollection 2022. Impact factor: Publication type: Paper in international publication Authors: Aragon, David; Azarfane, Brahim; Banderas Garcia, Sandra; Garcia-Arumi, Jose; Garrell-Salat, Xavier; Otero-Romero, Susana; Sanchez-Montalva, Adrian; Trejo, Fernando; Zapata, Miguel Angel et al. DOI: 10.1136/bmjophth-2021-000867 Persistent thrombocytopenia predicts poor long-term survival in patients with antiphospholipid syndrome: a 38-year follow-up study. PMID: 34115832 Journal: RHEUMATOLOGY Year: 2022 Reference: Rheumatology (Oxford). 2022 Mar 2;61(3):1053-1061. doi: 10.1093/rheumatology/keab475. Impact factor: 7.58 Publication type: Paper in international publication Authors: Pardos-Gea, Jose, Marques-Soares, Joana R, Bujan, Segundo, Ordi-Ros, Jose, Alijotas-Reig, Jaume et al. DOI: 10.1093/rheumatology/keab475 Persistent thrombocytopenia predicts poor long-term survival in patients with antiphospholipid syndrome: a 38-year follow-up study. PMID: 34115832 Journal: RHEUMATOLOGY Year: 2022 Reference: Rheumatology (Oxford). 2022 Mar 2;61(3):1053-1061. doi: 10.1093/rheumatology/keab475. Impact factor: Publication type: Paper in international publication Authors: Alijotas-Reig, Jaume; Bujan, Segundo; Marques-Soares, Joana R; Ordi-Ros, Jose; Pardos-Gea, Jose et al. DOI: 10.1093/rheumatology/keab475 Personalized Surgery Service in a Tertiary Hospital: A Method to Increase Effectiveness, Precision, Safety and Quality in Maxillofacial Surgery Using Custom-Made 3D Prostheses and Implants. PMID: 36013033 Journal: Journal of Clinical Medicine Year: 2022 Reference: J Clin Med. 2022 Aug 16;11(16). pii: jcm11164791. doi: 10.3390/jcm11164791. Impact factor: Publication type: Paper in international publication Authors: Bescos-Atin, Coro; de-Pablo-Garcia-Cuenca, Alba; Masnou-Pratdesaba, Joan; Pamias-Romero, Jorge; Pujol-Pina, Rosa; Saez-Barba, Manel; Sala-Cunill, Anna; Siurana-Montilva, Sahyly; Valls-Comamala, Victoria et al. DOI: 10.3390/jcm11164791 Perspectives toward the development of advanced materials based on bacterial polysaccharides. PMID: 35770400 Journal: CURRENT MEDICINAL CHEMISTRY Year: 2022 Reference: Curr Med Chem. 2022 Jun 29. pii: CMC-EPUB-124889. doi: 10.2174/0929867329666220629152008. Impact factor: 4.53 Publication type: Paper in international publication Authors: Rafael, Diana; Marican, Adolfo; Duran-Lara, Esteban F; Vijayakumar, Sekar et al. DOI: 10.2174/0929867329666220629152008 Pertactin-Deficient Bordetella pertussis with Unusual Mechanism of Pertactin Disruption, Spain, 1986-2018. PMID: 35447067 Journal: EMERGING INFECTIOUS DISEASES Year: 2022 Reference: Emerg Infect Dis. 2022 May;28(5):967-976. doi: 10.3201/eid2805.211958. Impact factor: 6.883 Publication type: Paper in international publication Authors: Mir-Cros, Alba, Moreno-Mingorance, Albert, Martin-Gomez, M Teresa, Abad, Raquel, Bloise, Ivan, Campins, Magda, Gonzalez-Praetorius, Alejandro, Gutierrez, M Nieves, Martin-Gonzalez, Hector, Munoz-Almagro, Carmen et al. DOI: 10.3201/eid2805.211958 Pertactin-Deficient Bordetella pertussis with Unusual Mechanism of Pertactin Disruption, Spain, 1986-2018. PMID: 35447067 Journal: EMERGING INFECTIOUS DISEASES Year: 2022 Reference: Emerg Infect Dis. 2022 May;28(5):967-976. doi: 10.3201/eid2805.211958. Impact factor: Publication type: Paper in international publication Authors: Abad, Raquel; Bloise, Ivan; Campins, Magda; de Pablos, Manuela; Gonzalez-Lopez, Juan Jose; Gonzalez-Praetorius, Alejandro; Gutierrez, M Nieves; Larrosa, M Nieves; Martin-Gomez, M Teresa; Martin-Gonzalez, Hector et al. DOI: 10.3201/eid2805.211958 Perturbed hematopoiesis in individuals with germline DNMT3A overgrowth Tatton-Brown-Rahman syndrome. PMID: 34092059 Journal: HAEMATOLOGICA Year: 2022 Reference: Haematologica. 2022 Apr 1;107(4):887-898. doi: 10.3324/haematol.2021.278990. Impact factor: 9.941 Publication type: Paper in international publication Authors: Tovy, Ayala, Rosas, Carina, Gaikwad, Amos S, Medrano, Geraldo, Zhang, Linda, Reyes, Jaime M, Huang, Yung-Hsin, Arakawa, Tastuhiko, Kurtz, Kristen, Conneely, Shannon E et al. DOI: 10.3324/haematol.2021.278990 Perturbed hematopoiesis in individuals with germline DNMT3A overgrowth Tatton-Brown-Rahman syndrome. PMID: 34092059 Journal: HAEMATOLOGICA Year: 2022 Reference: Haematologica. 2022 Apr 1;107(4):887-898. doi: 10.3324/haematol.2021.278990. Impact factor: Publication type: Paper in international publication Authors: Aguilar, Rogelio; Arakawa, Tastuhiko; Brunetti, Lorenzo; Carter, Melissa T; Chen, Chun-Wei; Conneely, Shannon E; Gaikwad, Amos S; Gao, Anne; Goodell, Margaret A; Guzman, Anna G et al. DOI: 10.3324/haematol.2021.278990 Pevonedistat plus azacitidine vs azacitidine alone in higher-risk MDS/chronic myelomonocytic leukemia or low-blast percentage AML. PMID: 35728048 Journal: Blood Advances Year: 2022 Reference: Blood Adv. 2022 Jun 21. pii: 485649. doi: 10.1182/bloodadvances.2022007334. Impact factor: 6.799 Publication type: Paper in international publication Authors: Ades, Lionel, Girshova, Larisa, Doronin, Vadim A, Diez-Campelo, Maria, Valcarcel, David, Kambhampati, Suman, Viniou, Nora-Athina, Woszczyk, Dariusz, De Paz Arias, Raquel, Symeonidis, Argiris et al. DOI: 10.1182/bloodadvances.2022007334 Pevonedistat plus azacitidine vs azacitidine alone in higher-risk MDS/chronic myelomonocytic leukemia or low-blast percentage AML. PMID: 35728048 Journal: Blood Advances Year: 2022 Reference: Blood Adv. 2022 Sep 13;6(17):5132-5145. doi: 10.1182/bloodadvances.2022007334. Impact factor: Publication type: Paper in international publication Authors: Ades, Lionel; Anagnostopoulos, Achilles; De Paz Arias, Raquel; Diez-Campelo, Maria; Doronin, Vadim A; Faller, Douglas V; Fram, Robert J; Friedlander, Sharon; Girshova, Larisa; Kambhampati, Suman et al. DOI: 10.1182/bloodadvances.2022007334 Phage Therapy of Mycobacterium Infections: Compassionate-use of Phages in Twenty Patients with Drug-Resistant Mycobacterial Disease. PMID: 35676823 Journal: CLINICAL INFECTIOUS DISEASES Year: 2022 Reference: Clin Infect Dis. 2022 Jun 9. pii: 6604409. doi: 10.1093/cid/ciac453. Impact factor: 9.079 Publication type: Paper in international publication Authors: Davidson, Rebecca M, Cohen, Keira A, Whitney Brown, A, Belessis, Yvonne, Jacobs-Sera, Deborah, Freeman, Krista G, Cristinziano, Madison, Smith, Bailey E, Dedrick, Rebekah M, van Duin, David et al. DOI: 10.1093/cid/ciac453 Pharmacokinetic Characteristics of Nebulized Colistimethate Sodium Using Two Different Types of Nebulizers in Critically Ill Patients with Ventilator-Associated Respiratory Infections. PMID: 36358184 Journal: Antibiotics-Basel Year: 2022 Reference: Antibiotics (Basel). 2022 Nov 1;11(11). pii: antibiotics11111528. doi: 10.3390/antibiotics11111528. Impact factor: Publication type: Paper in international publication Authors: Avgeropoulou, Stavrina; Christodoulou, Eirini; Dokoumetzidis, Aristides; Koutsoukou, Antonia; Kyriakoudi, Anna; Markantonis, Sophia L; Moraitou, Eleni; Neroutsos, Efthymios; Pontikis, Konstantinos; Rello, Jordi et al. DOI: 10.3390/antibiotics11111528 Pharmacokinetics and pharmacodynamics of approved monoclonal antibody therapy for colorectal cancer. PMID: 36582117 Journal: Expert Opinion on Drug Metabolism & Toxicology Year: 2022 Reference: Expert Opin Drug Metab Toxicol. 2022 Nov;18(11):755-767. doi: 10.1080/17425255.2022.2160316. Epub 2022 Dec 29. Impact factor: Publication type: Paper in international publication Authors: Baraibar, Iosune; Elez, Elena; Gomez, Diego; Lopez, Daniel; Ros, Javier; Ros, Javier; Salva, Francesc; Saoudi Gonzalez, Nadia; Tabernero, Josep et al. DOI: 10.1080/17425255.2022.2160316 Pharmacokinetics of PEGylated Gold Nanoparticles: In Vitro-In Vivo Correlation. PMID: 35159859 Journal: Nanomaterials Year: 2022 Reference: Nanomaterials (Basel). 2022 Feb 1;12(3). pii: nano12030511. doi: 10.3390/nano12030511. Impact factor: 5.076 Publication type: Paper in international publication Authors: Manova, Alena; Bastus, Neus G; Moriones, Oscar H; Kohl, Yvonne; Dusinska, Maria; Runden-Pran, Elise; Puntes, Victor; Nelson, Andrew; Gabelova, Alena; Simon, Peter et al. DOI: 10.3390/nano12030511 Pharmacokinetics of PEGylated Gold Nanoparticles: In Vitro-In Vivo Correlation. PMID: 35159859 Journal: Nanomaterials Year: 2022 Reference: Nanomaterials (Basel). 2022 Feb 1;12(3). pii: nano12030511. doi: 10.3390/nano12030511. Impact factor: Publication type: Paper in international publication Authors: Bastus, Neus G; Dubaj, Tibor; Dusinska, Maria; Gabelova, Alena; Kohl, Yvonne; Kozics, Katarina; Manova, Alena; Moriones, Oscar H; Nelson, Andrew; Puntes, Victor et al. DOI: 10.3390/nano12030511 Pharmacologic Management Strategies of Asthma-Chronic Obstructive Pulmonary Disease Overlap. PMID: 35965052 Journal: IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA Year: 2022 Reference: Immunol Allergy Clin North Am. 2022 Aug;42(3):657-669. doi: 10.1016/j.iac.2022.05.002. Impact factor: Publication type: Review in international publication Authors: Hanania, Nicola A; Miravitlles, Marc et al. DOI: 10.1016/j.iac.2022.05.002 Pharmacotherapeutic interventions for the treatment of bacterial prostatitis. PMID: 35574695 Journal: EXPERT OPINION ON PHARMACOTHERAPY Year: 2022 Reference: Expert Opin Pharmacother. 2022 Jun 27:1-11. doi: 10.1080/14656566.2022.2077101. Impact factor: 3.889 Publication type: Review in international publication Authors: Marquez-Algaba, Ester, Burgos, Joaquin, Almirante, Benito et al. DOI: 10.1080/14656566.2022.2077101 Pharmacotherapeutic interventions for the treatment of bacterial prostatitis. PMID: 35574695 Journal: EXPERT OPINION ON PHARMACOTHERAPY Year: 2022 Reference: Expert Opin Pharmacother. 2022 Jun;23(9):1091-1101. doi: 10.1080/14656566.2022.2077101. Epub 2022 Jun 27. Impact factor: Publication type: Review in international publication Authors: Almirante, Benito; Burgos, Joaquin; Marquez-Algaba, Ester et al. DOI: 10.1080/14656566.2022.2077101 Pharmacotherapeutic management of advanced therapy drugs. PMID: 35379101 Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia H Year: 2022 Reference: Farm Hosp. 2022 Jan 27;46(2):88-95. Impact factor: 0 Publication type: Paper in international publication Authors: Poveda-Andres, Jose Luis, Ruiz-Caldes, Maria Jose, Carrera-Soler, Maria Jose, Clopes-Estela, Ana, Flores-Moreno, Sandra, Garcia-Pellicer, Javier, Giraldez-Quiroga, Miriam, Lopez-Briz, Eduardo, Lozano-Blazquez, Ana, Megias-Vericat, Juan Eduardo et al. DOI: 10.7399/fh.13036 Pharmacotherapeutic management of advanced therapy drugs. PMID: 35379101 Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia H Year: 2022 Reference: Farm Hosp. 2022 Jan 27;46(2):88-95. Impact factor: Publication type: Paper in international publication Authors: Carrera-Soler, Maria Jose; Clopes-Estela, Ana; Flores-Moreno, Sandra; Garcia-Pellicer, Javier; Giraldez-Quiroga, Miriam; Lopez-Briz, Eduardo; Lozano-Blazquez, Ana; Megias-Vericat, Juan Eduardo; Poveda-Andres, Jose Luis; Ruiz-Caldes, Maria Jose et al. DOI: 10.7399/fh.13036 Phase 2 Trial (POLA Study) of Lurbinectedin plus Olaparib in Patients with Advanced Solid Tumors: Results of Efficacy, Tolerability, and the Translational Study. PMID: 35205662 Journal: Cancers Year: 2022 Reference: Cancers (Basel). 2022 Feb 12;14(4). pii: cancers14040915. doi: 10.3390/cancers14040915. Impact factor: 6.639 Publication type: Paper in international publication Authors: Poveda, Andres, Lopez-Reig, Raquel, Oaknin, Ana, Redondo, Andres, Rubio, Maria Jesus, Guerra, Eva, Farinas-Madrid, Lorena, Gallego, Alejandro, Rodriguez-Freixinos, Victor, Fernandez-Serra, Antonio et al. DOI: 10.3390/cancers14040915 Phase 2 Trial (POLA Study) of Lurbinectedin plus Olaparib in Patients with Advanced Solid Tumors: Results of Efficacy, Tolerability, and the Translational Study. PMID: 35205662 Journal: Cancers Year: 2022 Reference: Cancers (Basel). 2022 Feb 12;14(4). pii: cancers14040915. doi: 10.3390/cancers14040915. Impact factor: Publication type: Paper in international publication Authors: Farinas-Madrid, Lorena; Fernandez-Serra, Antonio; Gallego, Alejandro; Guerra, Eva; Juan, Oscar; Lopez-Guerrero, Jose A; Lopez-Reig, Raquel; Oaknin, Ana; Poveda, Andres; Redondo, Andres et al. DOI: 10.3390/cancers14040915 Phase I, first-in-human study of MSC-1 (AZD0171), a humanized anti-leukemia inhibitory factor monoclonal antibody, for advanced solid tumors. PMID: 35921760 Journal: ESMO Open Year: 2022 Reference: ESMO Open. 2022 Aug;7(4):100530. doi: 10.1016/j.esmoop.2022.100530. Epub 2022 Jul 31. Impact factor: Publication type: Paper in international publication Authors: Anido, J; Borazanci, E; Brana, I; Garralda, E; Giblin, P; Hallett, R M; Hilbert, J; Hoff, D V; Hoffman, K; Hua, F et al. DOI: 10.1016/j.esmoop.2022.100530 Pagination First page « First Previous page ‹ Previous … Page 237 Page 238 Page 239 Page 240 Current page 241 Page 242 Page 243 Page 244 Page 245 … Next page Next › Last page Last »
